By Market News Video Staff, Wednesday, November 24, 2:34 PM ET
Johnson & Johnson (NYSE:JNJ) said today it is recalling some of its Tylenol Cold Multi-Symptom products because of the labeling. J&J said the labels did not properly list the alcohol content in the products, and there have been no risks reported from use of the products. The company recalled children’s Benadryl and Motrin earlier in the week.
At 14.42% of the fund, Johnson & Johnson (NYSE:JNJ) is the top holding of the Health Care Select Sector SPDR Fund (AMEX:XLV). Pfizer (NYSE:PFE) is the second-largest holding in the fund at 11.06% of the portfolio, followed by Merck (NYSE:MRK) at 8.91% On the day, XLV is higher by about 0.9% despite the the recall by Johnson & Johnson.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.
This Article's Word Cloud:AMEXBenadrylHealthInvestmentJohnsonMerckNYSEPortfolioSectorSelectSymptomTylenolaboutallocationallowsassetbecausebondsclassescommoditiescompanycompletecompletelycountriesdesigneddespiteflexibilityfollowfollowedfundgrowthguidelineshavehigherholdinginvestorslabelsleadsperformanceportfolioproductsprogramproperlyrecallriskssaidshortstockstermsthere
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.